Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.
about
Neutrophils in Cancer: Two Sides of the Same CoinCXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes.Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinoma.Fibroblast α11β1 integrin regulates tensional homeostasis in fibroblast/A549 carcinoma heterospheroidsThe possible link between elevated serum levels of epithelial cell-derived neutrophil-activating peptide-78 (ENA-78/CXCL5) and autoimmunity in autistic children.Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and PrognosisIncreased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.Skin telocytes versus fibroblasts: two distinct dermal cell populations.CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma.From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation.Protumor and antitumor functions of neutrophil granulocytes.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Transcriptional Regulation of CXCL5 in HIV-1-Infected Macrophages and Its Functional Consequences on CNS Pathology.CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma.Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness.Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.The clinical significance of CXCL5 in non-small cell lung cancer.Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma.Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer.CXCL5 secreted from adipose tissue-derived stem cells promotes cancer cell proliferation.The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma.Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis.Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic MetastasisThe Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium
P2860
Q26773072-0A95106D-80C5-4735-8954-D2094D3951D9Q33562564-EA96F714-D804-4175-9940-F09A7FC160DDQ33706930-83A010DE-8FC3-4244-BB77-E4CA2B0D9812Q35215701-58066FA4-5E46-4236-BD7D-A31A067ACA5BQ35222567-DF4D85DC-3BE0-4DBE-9ED3-134CF3F598DBQ35995682-79D0D946-30C4-4DF9-A054-9F3893EA75AAQ36073222-ECCD1AD1-9660-478F-8B73-15C95323A37CQ36092860-3D24CCCC-807E-478C-8EEE-BF0CBD1431F2Q36232813-3AD8D2E5-48C9-4427-AF84-B2C39DC25F81Q37560269-681ECA08-197C-458B-94A9-105BCF61D2ECQ38045235-C88E9FC2-88DE-4D17-A614-80EFC5488B34Q38046098-4E4E3E9A-D169-429D-83E2-24A4BEDCDCDCQ38812588-FB820412-476C-495B-8B9E-963B4F697325Q38925831-25A57519-0F77-4881-A8D1-33960C5C27AEQ39049863-7C854244-1292-411C-909C-4E508826E25EQ42371988-C39B623B-CF31-4C60-9C02-F4B49EFE89A9Q45039242-02443710-0611-4DC3-8D2C-F5AF86FBC08FQ47101861-6797EB59-8EB3-4E05-9B6E-6C88981760B3Q47621546-1EDE484E-7B12-4803-8696-A41BF585E87BQ47931449-A679F551-3166-4A47-A91C-4DAEEF12919AQ49967651-0B1A3327-E77B-4D43-9F5E-A9D0F194ACDEQ50040819-8B208399-0BAB-402E-9088-1DC815C44B0BQ50350640-EE49819F-0DA5-4087-B9C6-3A9C91D83617Q52729640-6CEC6145-B90F-40AA-BC89-73FD0C61E935Q53002740-98054512-ADFD-4977-9882-94DE68C82FA4Q55209569-FE3B7565-A481-4EBE-A62F-BA43FD01DB16Q58590850-A40F0B71-2C51-4D64-AB96-611238C948F9Q59133892-F000F07B-63BF-4792-BD47-C6C6D738E1E5
P2860
Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Identification of CXCL5/ENA-78 ...... cancer-associated fibroblasts.
@en
Identification of CXCL5/ENA-78 ...... cancer-associated fibroblasts.
@nl
type
label
Identification of CXCL5/ENA-78 ...... cancer-associated fibroblasts.
@en
Identification of CXCL5/ENA-78 ...... cancer-associated fibroblasts.
@nl
prefLabel
Identification of CXCL5/ENA-78 ...... cancer-associated fibroblasts.
@en
Identification of CXCL5/ENA-78 ...... cancer-associated fibroblasts.
@nl
P2093
P2860
P356
P1476
Identification of CXCL5/ENA-78 ...... cancer-associated fibroblasts.
@en
P2093
Hasita Horlad
Hideo Baba
Hirofumi Jono
Hirohisa Okabe
Hiromitsu Hayashi
Hiroshi Takamori
Keisuke Miyake
Kosuke Mima
Masaaki Iwatsuki
Mitsuharu Ueda
P2860
P304
P356
10.1002/IJC.27496
P577
2012-03-27T00:00:00Z